Clinical Trials Browser

Phase 2 × Non-squamous Cell Non-Small Cell Lung Cancer × anlotinib × Clear all

NCT03778138 2018-12-19

ALTER-L025

Phase 2 Unknown

Non-squamous Cell Non-Small Cell Lung Cancer